Sebastien Chateauvieux
Overview
Explore the profile of Sebastien Chateauvieux including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
560
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chateauvieux S, Gaigneaux A, Gerard D, Orsini M, Morceau F, Orlikova-Boyer B, et al.
Haematologica
. 2019 Oct;
105(6):e280-e284.
PMID: 31582551
No abstract available.
2.
Orsini M, Chateauvieux S, Rhim J, Gaigneaux A, Cheillan D, Christov C, et al.
Cell Death Differ
. 2018 Dec;
26(9):1796-1812.
PMID: 30546074
Elevated levels of the pro-inflammatory cytokine tumor necrosis factor-α (TNFα) inhibit erythropoiesis and cause anemia in patients with cancer and chronic inflammatory diseases. TNFα is also a potent activator of...
3.
Mazumder A, Lee J, Talhi O, Cerella C, Chateauvieux S, Gaigneaux A, et al.
Cancer Lett
. 2018 Sep;
438:197-218.
PMID: 30205168
We synthetized and investigated the anti-leukemic potential of the novel cytostatic bis(4-hydroxycoumarin) derivative OT-55 which complied with the Lipinski's rule of 5 and induced differential toxicity in various chronic myeloid...
4.
Ji S, Lee J, Schror J, Mazumder A, Jang D, Chateauvieux S, et al.
Cancer Lett
. 2017 Dec;
416:109-123.
PMID: 29246646
Stemphol (STP) is a novel druggable phytotoxin triggering mixed apoptotic and non-apoptotic necrotic-like cell death in human acute myeloid leukemia (AML). Use of several chemical inhibitors highlighted that STP-induced non-canonical...
5.
2,5-Dimethyl-celecoxib inhibits cell cycle progression and induces apoptosis in human leukemia cells
Sobolewski C, Rhim J, Legrand N, Muller F, Cerella C, Mack F, et al.
J Pharmacol Exp Ther
. 2015 Sep;
355(2):308-28.
PMID: 26330537
Cyclooxygenase-2 (COX-2) is an essential regulator of cancer promotion and progression. Extensive efforts to target this enzyme have been developed to reduce growth of cancer cells for chemopreventive and therapeutic...
6.
Morceau F, Chateauvieux S, Orsini M, Trecul A, Dicato M, Diederich M
Biotechnol Adv
. 2015 Apr;
33(6 Pt 1):785-97.
PMID: 25886879
In addition to apoptosis resistance and cell proliferation capacities, the undifferentiated state also characterizes most cancer cells, especially leukemia cells. Cell differentiation is a multifaceted process that depends on complex...
7.
Hajjouli S, Chateauvieux S, Teiten M, Orlikova B, Schumacher M, Dicato M, et al.
Molecules
. 2014 Sep;
19(9):14649-66.
PMID: 25230121
Eurycomanone and eurycomanol are two quassinoids from the roots of Eurycoma longifolia Jack. The aim of this study was to assess the bioactivity of these compounds in Jurkat and K562...
8.
Morceau F, Chateauvieux S, Gaigneaux A, Dicato M, Diederich M
Int J Mol Sci
. 2013 Jul;
14(7):14744-70.
PMID: 23860209
Genomic analyses estimated that the proportion of the genome encoding proteins corresponds to approximately 1.5%, while at least 66% are transcribed, suggesting that many non-coding DNA-regions generate non-coding RNAs (ncRNAs)....
9.
Trecul A, Morceau F, Gaigneaux A, Orsini M, Chateauvieux S, Grandjenette C, et al.
Cancer Lett
. 2013 Jul;
340(1):30-42.
PMID: 23811288
Constitutive activity of kinases has been reported in many types of cancers, so that inhibition of "onco-kinases" became a validated anti-cancer strategy. We found that the polyphenol 13c, a tri-vanillate...
10.
De Bosscher K, Beck I, Dejager L, Bougarne N, Gaigneaux A, Chateauvieux S, et al.
Cell Mol Life Sci
. 2013 Jun;
71(1):143-63.
PMID: 23784308
Glucocorticoids (GCs) block inflammation via interference of the liganded glucocorticoid receptor (GR) with the activity of pro-inflammatory transcription factors NF-κB and AP-1, a mechanism known as transrepression. This mechanism is...